Hospital-Acquired Infection Control Market Outlook Highlights Strategic Opportunities Across The Industry

The hospital-acquired infection control industry is gaining significant momentum as healthcare facilities worldwide intensify efforts to curb infections that arise during hospital stays. Advances in technology, stricter regulations, and growing awareness of infection risks are all contributing to the sector's promising outlook. Let's explore the current market size, key players, emerging trends, and the segmentation shaping this vital industry's future.

Projected Market Size and Growth of the Hospital-Acquired Infection Control Industry
The hospital-acquired infection control market is anticipated to experience robust growth in the coming years, reaching a valuation of $46.32 billion by 2030. This expansion is expected to proceed at a compound annual growth rate (CAGR) of 5.3%. The predicted increase is driven by factors such as heightened regulatory scrutiny regarding infection control practices, wider adoption of automated sterilization technologies, and growing demand for rapid microbial testing methods. Additionally, the expansion of surveillance and reporting systems, coupled with rising investments in infection prevention infrastructure within hospitals, plays a crucial role. Trends likely to influence this market include a stronger focus on minimizing cross-contamination, enhanced sterilization and disinfection protocols, continuous infection monitoring, growth of automated disinfection solutions, and a surge in comprehensive infection prevention strategies.

The hospital-acquired infection control market size has grown strongly in recent years. It will grow from $35.75 billion in 2025 to $37.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising incidence of hospital-acquired infections, increased use of invasive medical procedures, growing awareness of patient safety standards, expansion of intensive care units, stricter hospital hygiene regulations.

Download a free sample of the hospital-acquired infection control market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Drivers Behind Hospital Infection Control Market Expansion
One of the primary forces propelling growth in this market is the increasing enforcement of stringent regulations aimed at reducing hospital-acquired infections. Healthcare providers are under pressure to comply with these mandates to ensure patient safety and avoid penalties.
In parallel, the rising incorporation of advanced technologies like automated sterilizers and rapid microbial testing systems is driving demand. These innovations not only improve efficiency but also enhance the effectiveness of infection control measures, encouraging wider adoption across healthcare institutions.

Leading Organizations in the Hospital-Acquired Infection Control Industry
The competitive landscape involves several influential companies, including Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton dic*kinson and Company, Reckitt Benckiser Group plc., Ecolab Inc., Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc., Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., and Zep Inc.
In a notable move in August 2024, MicroCare, LLC, a US-based company specializing in cleaning and disinfecting medical products, acquired ICT Infection Control Technologies. This acquisition aims to broaden MicroCare's healthcare portfolio by integrating ICT's infection control chemistries, particularly used in dental and medical markets, with MicroCare's existing cleaning and lubrication solutions. This strategic partnership is designed to strengthen MicroCare's position in the rapidly expanding medical infection prevention market and improve the safety and effectiveness of cleaning products for healthcare environments.

View the full hospital-acquired infection control market report:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovative Trends Shaping the Hospital-Acquired Infection Control Market
Technology advancements are at the forefront of shaping this industry's future. Many companies are investing in AI systems that enhance early detection of infections like sepsis, thereby improving patient outcomes.
For example, in April 2024, Prenosis Inc., a US-based medical clinic, received FDA marketing authorization for its Sepsis ImmunoScore. This AI-powered tool is the first of its kind to predict sepsis by analyzing real-time data, enabling clinicians to intervene swiftly. The system is intended to assist healthcare professionals rather than replace them, aiming to reduce healthcare costs and improve patient care through faster diagnosis and treatment.

Segment Breakdown and Market Forecast for Hospital-Acquired Infection Control
The hospital-acquired infection control market is divided into several key segments:
1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention and Surveillance Software, and other products.
2) By Technology: Phenotypic Methods and Genotypic Methods.
3) By Diseases: Hospital-Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, and others.
4) By Application: Disease Testing and Drug-Resistance Testing.
5) By End User: Hospitals, ICUs, Ambulatory Surgical Centers, Diagnostic Centers, Nursing Homes, Maternity Centers, and other users.

Further subcategories include:
- Sterilizers such as Steam, Ethylene Oxide, and Hydrogen Peroxide types.
- Disinfectors including Washer and Automated Disinfectors.
- Endoscope Reprocessors like High-Level Disinfection and Automated variants.
- Microbial Testing Instruments split into Culture Systems and Rapid Testing Systems.
- Consumables such as Sterilization Wraps, Filters, and Personal Protective Equipment (PPE).
- Disinfectants classified into Alcohol-based, Chlorine-based, and Quaternary Ammonium Compounds.
- Infection Prevention and Surveillance Software, including Surveillance and Data Management solutions.
- Other products encompassing Cleaning Equipment and Air Purification Systems.

This detailed segmentation allows for a comprehensive understanding of the diverse technologies, products, and applications contributing to the growth and innovation within the hospital-acquired infection control market.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.